Reza Zadno Procept Bio Robotics Corp (PRCT) insider trading activity

PRCT Quotes by TradingView

Reza Zadno is President, CEO of PROCEPT BioRobotics Corp. Currently has a direct ownership of 173,070 shares of PRCT, which is worth approximately $10.7 Million. The most recent transaction as insider was on Mar 18, 2025, when has been sold 5,475 shares (Common Stock) at a price of $57.06 per share, resulting in proceeds of $312,403. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 173K
13.29% 3M change
28.28% 12M change
Total Value Held $10.7 Million

Reza Zadno Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2025
SELL
Open market or private sale
$312,403 $57.06 p/Share
5,475 Reduced 3.07%
173,070 Common Stock
Mar 06 2025
SELL
Open market or private sale
$975,809 $61.31 p/Share
15,916 Reduced 8.18%
178,545 Common Stock
Mar 03 2025
BUY
Grant, award, or other acquisition
-
41,699 Added 17.66%
194,461 Common Stock
Dec 04 2024
SELL
Open market or private sale
$2,578,092 $97.57 p/Share
26,423 Reduced 14.75%
152,762 Common Stock
Nov 27 2024
SELL
Open market or private sale
$2,605,276 $98.61 p/Share
26,420 Reduced 12.85%
179,185 Common Stock
Nov 20 2024
SELL
Open market or private sale
$2,455,474 $92.94 p/Share
26,420 Reduced 11.39%
205,605 Common Stock
Nov 13 2024
SELL
Open market or private sale
$2,489,556 $94.23 p/Share
26,420 Reduced 10.22%
232,025 Common Stock
Oct 30 2024
SELL
Open market or private sale
$26,249,951 $91.0 p/Share
288,461 Reduced 52.74%
258,445 Common Stock
Oct 30 2024
BUY
Exercise of conversion of derivative security
$1,260,574 $4.37 p/Share
288,461 Added 34.53%
546,906 Common Stock
Jul 31 2024
BUY
Exercise of conversion of derivative security
$102,625 $4.37 p/Share
23,484 Added 8.33%
258,445 Common Stock
Mar 18 2024
SELL
Open market or private sale
$263,242 $48.83 p/Share
5,391 Reduced 2.19%
241,319 Common Stock
Mar 06 2024
SELL
Open market or private sale
$428,383 $46.67 p/Share
9,179 Reduced 3.59%
246,710 Common Stock
Mar 06 2024
BUY
Grant, award, or other acquisition
-
54,933 Added 17.67%
255,889 Common Stock
Oct 18 2023
BUY
Exercise of conversion of derivative security
$22,496 $4.37 p/Share
5,148 Added 2.5%
200,956 Common Stock
Apr 28 2023
BUY
Exercise of conversion of derivative security
$87,378 $4.37 p/Share
19,995 Added 9.27%
195,808 Common Stock
Apr 04 2023
BUY
Exercise of conversion of derivative security
$87,496 $4.37 p/Share
20,022 Added 10.22%
175,813 Common Stock
Mar 16 2023
SELL
Open market or private sale
$169,866 $31.84 p/Share
5,335 Reduced 3.31%
155,791 Common Stock
Feb 16 2023
BUY
Grant, award, or other acquisition
-
65,789 Added 28.99%
161,126 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
$1,154,987 $29.38 p/Share
39,312 Added 29.2%
95,337 Common Stock
Sep 17 2021
BUY
Conversion of derivative security
-
3,394 Added 5.71%
56,025 Common Stock
RZ

Reza Zadno

President, CEO
Redwood City, CA

Track Institutional and Insider Activities on PRCT

Follow PROCEPT BioRobotics Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRCT shares.

Notify only if

Insider Trading

Get notified when an Procept Bio Robotics Corp insider buys or sells PRCT shares.

Notify only if

News

Receive news related to PROCEPT BioRobotics Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PRCT